Physician profile
Raina Gupta
NPI 1366698482
$16,394.63
in general payments reported to CMS, 2019-2025
14 companies · $6,524 in 2025
The $6,524 reported for 2025 was more than what 87% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.05 · 2020: $84.86 · 2022: $107 · 2023: $1,162 · 2024: $8,446 · 2025: $6,524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $3,178 · Travel and Lodging: $1,619 · Education: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,078.00 |
| Food and Beverage | $3,178.21 |
| Travel and Lodging | $1,619.28 |
| Education | $256.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $8,507.55 | 2019-2025 | |
| Fisher & Paykel Healthcare INC | $3,308.93 | 2025 | Fisher & Paykel Healthcare |
| Lilly USA, LLC | $2,400.00 | 2025 | Zepbound |
| Inspire Medical Systems, INC. | $1,264.66 | 2023-2025 | Inspire |
| Harmony Biosciences LLC | $459.87 | 2023-2025 | Wakix |
| Aerin Medical INC. | $98.58 | 2025 | |
| Depuy Synthes Sales INC. | $84.86 | 2020 | |
| Itamar Medical INC | $81.94 | 2023 | Watchpatone |
| Idorsia Pharmaceuticals US INC | $59.05 | 2024 | Quviviq |
| Avadel Cns Pharmaceuticals, LLC | $41.61 | 2024 | Lumryz |
| Takeda Pharmaceuticals U.S.A., INC. | $26.62 | 2025 | |
| Vanda Pharmaceuticals INC. | $25.61 | 2019 | |
| Abbvie INC. | $19.07 | 2022 | |
| Resmed Corp | $16.28 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raina Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.